Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We are very excited to launch our new website! Please take a few moments to click around and explore...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...